Interventional Oncology Market Poised to Reach USD 4.12 Billion by 2031, Driven by Impressive 7.6% CAGR: AMR

Allied Market Research has published a study report with the title Interventional Oncology Market Size was Valued at USD 1.98 billion in 2021, and is Projected to Garner USD 4.12 billion by 2031, registering a CAGR of 7.6% from 2022 to 2031. The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and evolving market trends. The market study is a helpful source of information for the frontrunners, new entrants, investors, and shareholders in crafting strategies for the future and heightening their position in the market.

Covid-19 scenario-

• The Covid-19 outbreak impacted the global interventional oncology market negatively. Lockdowns imposed by the government led manufacturers of interventional oncology devices to face many challenges such as disruption of supply chain for the raw materials and the closure of various production facilities.
• In addition, the pandemic led to unavailability of skilled lab professionals to run diagnostic tests, inadequate distribution of funds for research in academic and research institutes, limited operations in most industries due to temporary lockdown of manufactures and academic institutes, are leading to a scarcity in the supply of the interventional oncology products to end users.
• Many number of medical colleges and hospitals around the world were restructured to increase accommodation of more patients diagnosed with COVID-19. This is another reason for which the market suffered losses.
• However, innovative initiatives by key players to develop a new category of interventional oncology robotics to perform surgery of tumors boost the market growth post-pandemic.

What Are the Market Drivers for Interventional Oncology?

The increase in the prevalence of chronic diseases, growing demand for minimally invasive therapeutics, a surge in awareness regarding cancer and acceptance of interventional oncology procedures for detecting and treating cancer, and rise in investments in research and development by biopharmaceutical industry players driving the growth of the global interventional oncology market. Based on product, the particle embolization segment contributed to the highest share in 2021 and would dominate through the forecast period.

Get Sample PDF Report with Graphs and Figures Here: https://www.alliedmarketresearch.com/request-sample/3702

Top Interventional oncology companies

• Alpinion Medical Systems Co. Ltd.,
• AngioDynamics
• Boston Scientific Corporation
• Hologic, Inc.
• Medtronic Plc.
• Merit Medical
• Profound Medical
• Siemens Healthineers
• Teleflex Incorporated
• Terumo Corporation

Interventional oncology market segmentation can be done based on several factors, including:

The report offers detailed segmentation of the global interventional oncology market based on product and region. The report provides an analysis of each segment and sub-segment with the help of tables and figures. This analysis helps market players, investors, and new entrants in determining the sub-segments to be tapped on to achieve growth in the coming years.

Based on product, the particle embolization segment accounted for nearly two-fifths of the total market share in 2021, and is projected to rule the roost by the end of 2031. The support devices segment, however, would cite the fastest CAGR of 8.8% throughout the forecast period. The other product discussed in the report is ablation.

Based on region, the market across North America contributed to nearly half of the total market revenue in 2021, and is expected to lead the trail by 2031. The Asia-Pacific market, on the other hand, would grow at the fastest CAGR of 9.8% from 2022 to 2031. The other two provinces discussed in the report include Europe and LAMEA.

Purchase the Report: https://www.alliedmarketresearch.com/purchase-enquiry/3702

Our Market Research Solution Provides You Answer to Below Mentioned Question:

• Which are the driving factors responsible for the growth of market?
• Which are the roadblock factors of this market?
• What are the new opportunities, by which market will grow in coming years?
• What are the trends of this market?
• Which are main factors responsible for new product launch?
• How big is the global & regional market in terms of revenue, sales and production?
• How far will the market grow in forecast period in terms of revenue, sales and production?
• Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
• How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
• Which region has more opportunities?

By Region Outlook 

• North America
  (U.S., Canada, Mexico)
• Europe
  (Germany, France, UK, Italy, Spain, Rest of Europe)
• Asia-Pacific
  (Japan, China, India, Rest of Asia-Pacific)
• LAMEA
  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)

Contact Details:
David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.